|
BAXTER GRANTS
STOCK OPTIONS TO MORE THAN 41,000 BAXTER TEAM MEMBERS
Company Provides Team Members with the Opportunity
to Share in its Success
DEERFIELD, Ill., March
19, 2001 - Baxter International
Inc. (NYSE: BAX) announced today that the company has granted 100 stock
options to eligible Baxter employees worldwide. For the first time in
Baxter's history, more than 41,000 individuals are receiving the opportunity
to participate in the shareholder value they help to create.
"This global stock option plan will enable our team members to benefit
directly from the results of our collective focus on driving profitable
growth and continuing improvement in operational excellence," said
Harry M. Jansen Kraemer, Jr., chairman and chief executive officer.
Baxter's 2001 Global Stock Option Plan aligns the incentives of Baxter
team members with those of Baxter's shareholders.
"Baxter's success is a result of the hard work, dedication and commitment
of everyone on our team. This plan is an important step forward in our
efforts to build the best team in health care and become one of the most
admired companies," Kraemer continued.
Baxter International Inc. is a global medical products and services company
that, through its subsidiaries, provides critical therapies for people
with life-threatening conditions. Baxter's products and services in bioscience
(biopharmaceuticals, vaccines, biosurgery products and blood therapies),
medication delivery and renal therapy are used by health-care providers
and their patients in more than 100 countries.
FOR ADDITIONAL
INFORMATION:
 |
- Media Contacts:
- Margaret
Stanford Shubny, (847) 948-3951
-
- Investor Contacts:
- Neville Jeharajah,
(847) 948-2875
Mary Kay Ladone, (847) 948-3371
|
| |
|